IDT Biologika is a leading biologics CDMO providing development and manufacturing of Vaccines, Viral Vectors for Cell & Gene Therapeutics, Oncolytic Viruses, Virus-Like Particles, and aseptic fill-finish for other Biologics, with end-to-end capabilities serving companies worldwide.
Our North American CDMO site is a GMP-compliant facility (BSL-2) with a long history of contract manufacturing of clinical trial materials. It shares many of the state-of-the-art technologies used at our German facility that has both clinical and commercial capacity.
16 – 19 October 2023
Fira de Barcelona – MONTJUIC, Booth #49, Speaker: Dr. Martin Kächele – “Use of IDTs MVA platform for production of an experimental MERS vaccine – a case study”
If you want to further your career with a global leader in vaccines, cell and gene therapeutics, and other biologics CDMO services, visit IDT Biologika’s careers section for opportunities in Europe and North America.
Let us help you with your project. To ensure, we have the information we need, please fill out the form.